India's domestic drug market bounced back to growth in November. After clocking just 5.1% expansion in October, India's domestic pharma market registered 14.5% year-on-year growth in November.
A low base coupled with an early festive season helped pharmaceutical sales rise to $1.77 billion in November, with sales of most Indian drug manufacturers outpacing their foreign peers.
Data from market research firm AIOCD-AWACS showed that, in November last year, the domestic market saw 7% growth. In terms of moving annual turnover (MAT), November growth was 9.8%.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze